Explore key questions on contamination control strategies to support regulatory compliance and risk management in ...

Advanced biologics and patient-specific therapies reduce opportunities for terminal sterilization, elevating proactive microbial risk control and integrating QC microbiology into CCS authorship, risk ...

Environmental monitoring requirements in ATMP facilities, addressing regulatory compliance, GMP standards, and contamination ...

Viral safety will be a major challenge for the CGT industry for the foreseeable future, according to new analysis.

Biotech and pharmaceutical products must be manufactured in compliance with the current Good Manufacturing Practice (cGMP) regulations. Monitoring these areas meets the requirement for environmental ...

Materiality assessments help organizations translate risk and market signals into long-term strategy, writes M.S. in ...

The industry is seeing a shift toward integrated process intelligence and new regulatory pathways. Current trends across the pharmaceutical landscape reveal a decisive shift toward integrated process ...

AUSTIN, Texas, April 07, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: Pharmaceutical manufacturing is undergoing a structural shift as regulators demand higher standards for contamination ...

Pharmaceutical manufacturers engaged in biotechnology, pharmaceutical, medical device, home and personal care, and other related manufacturing industries need to be meticulous in creating and ...

AUSTIN, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: Pharmaceutical manufacturing is entering a period of structural transformation as regulators impose increasingly ...

U.S. Senator Gary Peters (MI) introduced bipartisan legislation to help prevent future infant formula shortages. Peters’ bill ...

Miniaturization has become a key strategy in modern assay development — reducing reagent consumption, increasing throughput, ...